> The FDA and the European Medicines Agency continue to cozy up, moving from confidence-building in their joint GMP inspections to reliance upon each other. Story
> GlaxoSmithKline ($GSK) and Pfizer ($PFE) say they will provide 180 million doses of discounted pneumococcal vaccine for use by the Global Alliance for Vaccines and Immunization. Story
> Covidien ($COV) says it plans to spin off its $2 billion pharmaceuticals business, creating a public company. Article
> DSM Sinochem Pharmaceuticals will build a production facility for semi-synthetic cephalosporins in Zibo, China. Story
> Pfizer ($PFE) has put three real estate lots--the last of its presence in Brooklyn--on the market. Item
> Contract service provider Advanced BioScience Labs has hired industry vet Claire Zhang to lead its downstream bioprocessing group. Item
> Lonza has expanded its early-phase, small-molecule manufacturing capacity in Nansha, China. Announcement
> Tom Flachmeyer has joined Prolong Pharmaceuticals to head the engineering and facilities planning function for it oxygen therapeutic product, Sanguinate. Story